With more drugs in clinical trials than any other country, Chinese drugmakers are now shifting focus to the high-risk, high-reward field of creating truly original medicines to move beyond an era of imitation and intense competition
00:00/00:00
您的浏览器不支持 audio 标签。
Listen to this article
1x
As Chinese pharmaceutical companies make waves with a series of major
Amid systemic efficiency and a wave of innovation, the country’s biotech sector is expanding at a pace that has caught the market…
‘If we’re not careful, every drug could be made in China,’ warned former head of US Food and Drug Administration in May.
Chinese drugmakers are seeing a deeper and wider presence overseas, with homegrown innovative pharmaceuticals underpinned by a…
The country’s drug evaluation agency registered a jump in new drug and clinical trial applications, signaling a robust pivot…
Home-grown therapies account for 80 per cent of approvals in first six months of the year.
Although a start-up’s recent triumph is seen as a ‘DeepSeek moment’, domestic players still trail world-beating pharma firms,…
